Global Injectable Sumatriptan Market Growth 2020-2025
According to this study, over the next five years the Injectable Sumatriptan market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Injectable Sumatriptan business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Sumatriptan market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Injectable Sumatriptan, covering the supply chain analysis, impact assessment to the Injectable Sumatriptan market size growth rate in several scenarios, and the measures to be undertaken by Injectable Sumatriptan companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
4mg
6mg
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Pfizer
Sun Pharma
Teva
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Injectable Sumatriptan consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Injectable Sumatriptan market by identifying its various subsegments.
Focuses on the key global Injectable Sumatriptan manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Injectable Sumatriptan with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Injectable Sumatriptan submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Sumatriptan Consumption 2015-2025
2.1.2 Injectable Sumatriptan Consumption CAGR by Region
2.2 Injectable Sumatriptan Segment by Type
2.2.1 4mg
2.2.2 6mg
2.2.3 Others
2.3 Injectable Sumatriptan Consumption by Type
2.3.1 Global Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
2.3.2 Global Injectable Sumatriptan Revenue and Market Share by Type (2015-2020)
2.3.3 Global Injectable Sumatriptan Sale Price by Type (2015-2020)
2.4 Injectable Sumatriptan Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Injectable Sumatriptan Consumption by Application
2.5.1 Global Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
2.5.2 Global Injectable Sumatriptan Value and Market Share by Type (2015-2020)
2.5.3 Global Injectable Sumatriptan Sale Price by Type (2015-2020)
3 Global Injectable Sumatriptan by Company
3.1 Global Injectable Sumatriptan Sales Market Share by Company
3.1.1 Global Injectable Sumatriptan Sales by Company (2018-2020)
3.1.2 Global Injectable Sumatriptan Sales Market Share by Company (2018-2020)
3.2 Global Injectable Sumatriptan Revenue Market Share by Company
3.2.1 Global Injectable Sumatriptan Revenue by Company (2018-2020)
3.2.2 Global Injectable Sumatriptan Revenue Market Share by Company (2018-2020)
3.3 Global Injectable Sumatriptan Sale Price by Company
3.4 Global Injectable Sumatriptan Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Injectable Sumatriptan Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Injectable Sumatriptan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Injectable Sumatriptan by Regions
4.1 Injectable Sumatriptan by Regions
4.2 Americas Injectable Sumatriptan Consumption Growth
4.3 APAC Injectable Sumatriptan Consumption Growth
4.4 Europe Injectable Sumatriptan Consumption Growth
4.5 Middle East & Africa Injectable Sumatriptan Consumption Growth
5 Americas
5.1 Americas Injectable Sumatriptan Consumption by Countries
5.1.1 Americas Injectable Sumatriptan Consumption by Countries (2015-2020)
5.1.2 Americas Injectable Sumatriptan Value by Countries (2015-2020)
5.2 Americas Injectable Sumatriptan Consumption by Type
5.3 Americas Injectable Sumatriptan Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Injectable Sumatriptan Consumption by Regions
6.1.1 APAC Injectable Sumatriptan Consumption by Regions (2015-2020)
6.1.2 APAC Injectable Sumatriptan Value by Regions (2015-2020)
6.2 APAC Injectable Sumatriptan Consumption by Type
6.3 APAC Injectable Sumatriptan Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Injectable Sumatriptan by Countries
7.1.1 Europe Injectable Sumatriptan Consumption by Countries (2015-2020)
7.1.2 Europe Injectable Sumatriptan Value by Countries (2015-2020)
7.2 Europe Injectable Sumatriptan Consumption by Type
7.3 Europe Injectable Sumatriptan Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Injectable Sumatriptan by Countries
8.1.1 Middle East & Africa Injectable Sumatriptan Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Injectable Sumatriptan Value by Countries (2015-2020)
8.2 Middle East & Africa Injectable Sumatriptan Consumption by Type
8.3 Middle East & Africa Injectable Sumatriptan Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Injectable Sumatriptan Distributors
10.3 Injectable Sumatriptan Customer
11 Global Injectable Sumatriptan Market Forecast
11.1 Global Injectable Sumatriptan Consumption Forecast (2021-2025)
11.2 Global Injectable Sumatriptan Forecast by Regions
11.2.1 Global Injectable Sumatriptan Forecast by Regions (2021-2025)
11.2.2 Global Injectable Sumatriptan Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Injectable Sumatriptan Forecast by Type
11.8 Global Injectable Sumatriptan Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Information
12.1.2 Injectable Sumatriptan Product Offered
12.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Pfizer
12.2.1 Company Information
12.2.2 Injectable Sumatriptan Product Offered
12.2.3 Pfizer Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 Sun Pharma
12.3.1 Company Information
12.3.2 Injectable Sumatriptan Product Offered
12.3.3 Sun Pharma Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sun Pharma Latest Developments
12.4 Teva
12.4.1 Company Information
12.4.2 Injectable Sumatriptan Product Offered
12.4.3 Teva Injectable Sumatriptan Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Teva Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Injectable Sumatriptan Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 4mg
Table 5. Major Players of 6mg
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
Table 9. Global Injectable Sumatriptan Revenue by Type (2015-2020) ($ million)
Table 10. Global Injectable Sumatriptan Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Injectable Sumatriptan Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Injectable Sumatriptan Consumption Market Share by Application (2015-2020)
Table 14. Global Injectable Sumatriptan Value by Application (2015-2020)
Table 15. Global Injectable Sumatriptan Value Market Share by Application (2015-2020)
Table 16. Global Injectable Sumatriptan Sale Price by Application (2015-2020)
Table 17. Global Injectable Sumatriptan Sales by Company (2017-2019) (K Units)
Table 18. Global Injectable Sumatriptan Sales Market Share by Company (2017-2019)
Table 19. Global Injectable Sumatriptan Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Injectable Sumatriptan Revenue Market Share by Company (2017-2019)
Table 21. Global Injectable Sumatriptan Sale Price by Company (2017-2019)
Table 22. Global Injectable Sumatriptan Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Injectable Sumatriptan Products Offered
Table 24. Injectable Sumatriptan Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Injectable Sumatriptan Consumption by Regions 2015-2020 (K Units)
Table 26. Global Injectable Sumatriptan Consumption Market Share by Regions 2015-2020
Table 27. Global Injectable Sumatriptan Value by Regions 2015-2020 ($ Millions)
Table 28. Global Injectable Sumatriptan Value Market Share by Regions 2015-2020
Table 29. Americas Injectable Sumatriptan Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Injectable Sumatriptan Consumption Market Share by Countries (2015-2020)
Table 31. Americas Injectable Sumatriptan Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Injectable Sumatriptan Value Market Share by Countries (2015-2020)
Table 33. Americas Injectable Sumatriptan Consumption by Type (2015-2020) (K Units)
Table 34. Americas Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
Table 35. Americas Injectable Sumatriptan Consumption by Application (2015-2020) (K Units)
Table 36. Americas Injectable Sumatriptan Consumption Market Share by Application (2015-2020)
Table 37. APAC Injectable Sumatriptan Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Injectable Sumatriptan Consumption Market Share by Countries (2015-2020)
Table 39. APAC Injectable Sumatriptan Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Injectable Sumatriptan Value Market Share by Regions (2015-2020)
Table 41. APAC Injectable Sumatriptan Consumption by Type (2015-2020) (K Units)
Table 42. APAC Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
Table 43. APAC Injectable Sumatriptan Consumption by Application (2015-2020) (K Units)
Table 44. APAC Injectable Sumatriptan Consumption Market Share by Application (2015-2020)
Table 45. Europe Injectable Sumatriptan Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Injectable Sumatriptan Consumption Market Share by Countries (2015-2020)
Table 47. Europe Injectable Sumatriptan Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Injectable Sumatriptan Value Market Share by Countries (2015-2020)
Table 49. Europe Injectable Sumatriptan Consumption by Type (2015-2020) (K Units)
Table 50. Europe Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
Table 51. Europe Injectable Sumatriptan Consumption by Application (2015-2020) (K Units)
Table 52. Europe Injectable Sumatriptan Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Injectable Sumatriptan Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Injectable Sumatriptan Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Injectable Sumatriptan Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Injectable Sumatriptan Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Injectable Sumatriptan Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Injectable Sumatriptan Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Injectable Sumatriptan Consumption Market Share by Application (2015-2020)
Table 61. Injectable Sumatriptan Distributors List
Table 62. Injectable Sumatriptan Customer List
Table 63. Global Injectable Sumatriptan Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Injectable Sumatriptan Consumption Market Forecast by Regions
Table 65. Global Injectable Sumatriptan Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Injectable Sumatriptan Value Market Share Forecast by Regions
Table 67. Global Injectable Sumatriptan Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Injectable Sumatriptan Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Injectable Sumatriptan Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Injectable Sumatriptan Value Market Share Forecast by Type (2021-2025)
Table 71. Global Injectable Sumatriptan Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Injectable Sumatriptan Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Injectable Sumatriptan Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Injectable Sumatriptan Value Market Share Forecast by Application (2021-2025)
Table 75. GlaxoSmithKline Product Offered
Table 76. GlaxoSmithKline Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Product Offered
Table 81. Pfizer Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Pfizer Basic Information, Company Total Revenue (in $ million), Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 85. Sun Pharma Product Offered
Table 86. Sun Pharma Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Sun Pharma Main Business
Table 88. Sun Pharma Latest Developments
Table 89. Sun Pharma Basic Information, Company Total Revenue (in $ million), Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Product Offered
Table 91. Teva Injectable Sumatriptan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Teva Main Business
Table 93. Teva Latest Developments
Table 94. Teva Basic Information, Company Total Revenue (in $ million), Injectable Sumatriptan Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Injectable Sumatriptan
Figure 2. Injectable Sumatriptan Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Injectable Sumatriptan Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Injectable Sumatriptan Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 4mg
Figure 7. Product Picture of 6mg
Figure 8. Product Picture of Others
Figure 9. Global Injectable Sumatriptan Consumption Market Share by Type (2015-2020)
Figure 10. Global Injectable Sumatriptan Value Market Share by Type (2015-2020)
Figure 11. Injectable Sumatriptan Consumed in Hospitals
Figure 12. Global Injectable Sumatriptan Market: Hospitals (2015-2020) (K Units)
Figure 13. Global Injectable Sumatriptan Market: Hospitals (2015-2020) ($ Millions)
Figure 14. Injectable Sumatriptan Consumed in Clinics
Figure 15. Global Injectable Sumatriptan Market: Clinics (2015-2020) (K Units)
Figure 16. Global Injectable Sumatriptan Market: Clinics (2015-2020) ($ Millions)
Figure 17. Injectable Sumatriptan Consumed in Others
Figure 18. Global Injectable Sumatriptan Market: Others (2015-2020) (K Units)
Figure 19. Global Injectable Sumatriptan Market: Others (2015-2020) ($ Millions)
Figure 20. Global Injectable Sumatriptan Consumption Market Share by Application (2015-2020)
Figure 21. Global Injectable Sumatriptan Value Market Share by Application (2015-2020)
Figure 22. Global Injectable Sumatriptan Sales Market Share by Company in 2017
Figure 23. Global Injectable Sumatriptan Sales Market Share by Company in 2019
Figure 24. Global Injectable Sumatriptan Revenue Market Share by Company in 2017
Figure 25. Global Injectable Sumatriptan Revenue Market Share by Company in 2019
Figure 26. Global Injectable Sumatriptan Sale Price by Company in 2019
Figure 27. Global Injectable Sumatriptan Consumption Market Share by Regions 2015-2020
Figure 28. Global Injectable Sumatriptan Value Market Share by Regions 2015-2020
Figure 29. Americas Injectable Sumatriptan Consumption 2015-2020 (K Units)
Figure 30. Americas Injectable Sumatriptan Value 2015-2020 ($ Millions)
Figure 31. APAC Injectable Sumatriptan Consumption 2015-2020 (K Units)
Figure 32. APAC Injectable Sumatriptan Value 2015-2020 ($ Millions)
Figure 33. Europe Injectable Sumatriptan Consumption 2015-2020 (K Units)
Figure 34. Europe Injectable Sumatriptan Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Injectable Sumatriptan Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Injectable Sumatriptan Value 2015-2020 ($ Millions)
Figure 37. Americas Injectable Sumatriptan Consumption Market Share by Countries in 2019
Figure 38. Americas Injectable Sumatriptan Value Market Share by Countries in 2019
Figure 39. Americas Injectable Sumatriptan Consumption Market Share by Type in 2019
Figure 40. Americas Injectable Sumatriptan Consumption Market Share by Application in 2019
Figure 41. United States Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 42. United States Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Injectable Sumatriptan Consumption Market Share by Countries in 2019
Figure 48. APAC Injectable Sumatriptan Value Market Share by Regions in 2019
Figure 49. APAC Injectable Sumatriptan Consumption Market Share by Type in 2019
Figure 50. APAC Injectable Sumatriptan Consumption Market Share by Application in 2019
Figure 51. China Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 52. China Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 59. India Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 60. India Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Injectable Sumatriptan Consumption Market Share by Countries in 2019
Figure 64. Europe Injectable Sumatriptan Value Market Share by Countries in 2019
Figure 65. Europe Injectable Sumatriptan Consumption Market Share by Type in 2019
Figure 66. Europe Injectable Sumatriptan Consumption Market Share by Application in 2019
Figure 67. Germany Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 69. France Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 70. France Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 71. UK Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 72. UK Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Injectable Sumatriptan Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Injectable Sumatriptan Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Injectable Sumatriptan Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Injectable Sumatriptan Consumption Market Share by Application in 2019
Figure 81. Egypt Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Injectable Sumatriptan Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Injectable Sumatriptan Value Growth 2015-2020 ($ Millions)
Figure 91. Global Injectable Sumatriptan Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Injectable Sumatriptan Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 94. Americas Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 95. APAC Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 96. APAC Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 97. Europe Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 98. Europe Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 101. United States Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 102. United States Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 103. Canada Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 104. Canada Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 105. Mexico Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 106. Mexico Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 107. Brazil Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 108. Brazil Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 109. China Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 110. China Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 111. Japan Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 112. Japan Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 113. Korea Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 114. Korea Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 117. India Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 118. India Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 119. Australia Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 120. Australia Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 121. Germany Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 122. Germany Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 123. France Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 124. France Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 125. UK Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 126. UK Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 127. Italy Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 128. Italy Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 129. Russia Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 130. Russia Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 131. Spain Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 132. Spain Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 133. Egypt Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 134. Egypt Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 135. South Africa Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 136. South Africa Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 137. Israel Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 138. Israel Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 139. Turkey Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 140. Turkey Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Injectable Sumatriptan Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Injectable Sumatriptan Value 2021-2025 ($ Millions)
Figure 143. GlaxoSmithKline Injectable Sumatriptan Market Share (2018-2020)
Figure 144. Pfizer Injectable Sumatriptan Market Share (2018-2020)
Figure 145. Sun Pharma Injectable Sumatriptan Market Share (2018-2020)
Figure 146. Teva Injectable Sumatriptan Market Share (2018-2020)
